Ronald C Petersen Selected Research

Ronald C Petersen Research Topics

Disease

280	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 04/2002
161	Cognitive Dysfunction 05/2024 - 11/2002
131	Dementia (Dementias) 04/2024 - 07/2003
60	Atrophy 05/2024 - 06/2005
36	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 10/2003
32	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2024 - 06/2006
21	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 04/2007
14	Tauopathies 05/2024 - 10/2007
14	Amyloidosis 11/2023 - 01/2010
14	Hypertension (High Blood Pressure) 01/2023 - 01/2011
13	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023 - 10/2008
12	Amyloid Plaque 02/2024 - 07/2008
11	Disease Progression 01/2023 - 07/2008
10	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 10/2008
9	Parkinsonian Disorders (Parkinsonism) 01/2023 - 11/2006
9	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 06/2006
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2012
9	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 09/2008
7	Neoplasms (Cancer) 01/2023 - 01/2005
7	Stroke (Strokes) 01/2022 - 05/2009
7	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2021 - 05/2015
6	Proteostasis Deficiencies 04/2024 - 02/2013
6	Vascular Diseases (Vascular Disease) 03/2024 - 05/2011
6	Prodromal Symptoms 02/2024 - 01/2013
6	Corticobasal Degeneration 12/2020 - 10/2003
5	Inflammation (Inflammations) 03/2024 - 12/2012
5	Infarction (Infarctions) 01/2023 - 10/2011
5	Hippocampal Sclerosis 01/2023 - 01/2017
5	Cerebral Cortical Thinning 01/2023 - 01/2019
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 02/2004
4	Aphasia (Dysphasia) 01/2024 - 01/2020
4	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022 - 06/2014
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2022 - 06/2014
4	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 03/2014
3	Genetic Risk Score 02/2024 - 01/2022
3	Chronic Renal Insufficiency 10/2023 - 01/2022
3	Synucleinopathies 01/2023 - 04/2013
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2018
3	Multiple Sclerosis 01/2020 - 07/2015
3	Chronic Disease (Chronic Diseases) 01/2019 - 05/2015
3	Memory Disorders (Memory Loss) 01/2019 - 01/2014
3	Meningioma (Meningiomas) 01/2019 - 12/2017
3	Obesity 01/2018 - 01/2015
2	limbic-predominant age-related TDP-43 encephalopathy 11/2023 - 01/2023
2	Obstructive Sleep Apnea 11/2023 - 01/2022
2	Apnea 11/2023 - 01/2020
2	Pathologic Processes 01/2023 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2014
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

171	Amyloid (Amyloid Fibrils)IBA 04/2024 - 02/2004
166	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2005
59	Apolipoproteins E (ApoE)IBA 02/2024 - 11/2002
41	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2007
37	ApolipoproteinsIBA 12/2022 - 11/2002
34	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2024 - 09/2008
30	Amyloid beta-PeptidesIBA 10/2023 - 02/2004
28	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2021 - 08/2010
23	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024 - 01/2016
15	ProgranulinsIBA 03/2024 - 11/2006
15	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2004
12	UbiquitinIBA 03/2024 - 06/2006
9	Apolipoprotein E4IBA 12/2019 - 10/2011
9	Protons (Proton)IBA 11/2017 - 05/2003
9	Vitamin E FDA LinkGeneric 09/2015 - 01/2005
8	Donepezil (Aricept)FDA LinkGeneric 05/2017 - 01/2005
7	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020 - 01/2009
6	LipidsIBA 03/2024 - 01/2011
6	SynucleinsIBA 01/2023 - 02/2007
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 06/2009
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2011
5	N 30IBA 01/2018 - 01/2009
4	Protein Isoforms (Isoforms)IBA 04/2023 - 10/2007
4	IronIBA 01/2022 - 12/2017
4	CeramidesIBA 11/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2008
3	Indicators and Reagents (Reagents)IBA 01/2023 - 02/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2009
3	LigandsIBA 01/2021 - 11/2013
3	HemosiderinIBA 01/2021 - 10/2013
3	PrionsIBA 12/2018 - 04/2016
3	Peptides (Polypeptides)IBA 12/2017 - 04/2009
3	Inositol (Myoinositol)IBA 11/2017 - 07/2008
3	florbetapirIBA 09/2015 - 10/2012
3	N-acetylaspartate (N-acetyl aspartate)IBA 03/2015 - 07/2008
2	Cholinergic Antagonists (Anticholinergics)IBA 05/2024 - 01/2016
2	Glial Fibrillary Acidic ProteinIBA 02/2024 - 01/2022
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023 - 01/2021
2	alpha-SynucleinIBA 01/2023 - 01/2017
2	Leucine (L-Leucine)FDA Link 10/2022 - 10/2016
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 08/2012
2	IGF-I-IGFBP-3 complex FDA Link 01/2022 - 03/2014

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2005
6	Secondary Prevention 09/2017 - 04/2006
4	General Anesthesia 10/2019 - 02/2016
3	Anesthesia 08/2020 - 11/2018
3	Activities of Daily Living (ADL) 01/2020 - 07/2009
3	Mediterranean Diet 01/2017 - 01/2010
2	Precision Medicine 03/2023 - 01/2022